DDMAC Says GSK Ad Is Branded Even Without Mention Of Drug Name
The journal ad promoted a new treatment for refractory chronic lymphocytic leukemia, but DDMAC said it was obviously Arzerra. This isn't GSK's first time with this problem.
The journal ad promoted a new treatment for refractory chronic lymphocytic leukemia, but DDMAC said it was obviously Arzerra. This isn't GSK's first time with this problem.